These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 19900548)

  • 1. Proceedings of the IX International Aromatase Conference. October 13-16, 2008. Shanghai, China.
    J Steroid Biochem Mol Biol; 2010 Feb; 118(4-5):195-315. PubMed ID: 19900548
    [No Abstract]   [Full Text] [Related]  

  • 2. Aromatase 2002. Proceedings of the VI International Aromatase Conference. Kyoto, Japan. October 26-30, 2002.
    J Steroid Biochem Mol Biol; 2003 Sep; 86(3-5):217-507. PubMed ID: 14623513
    [No Abstract]   [Full Text] [Related]  

  • 3. Progress in aromatase research and identification of key future directions.
    Dunbier AK; Hong Y; Masri S; Brown KA; Sabnis GJ; Palomares MR
    J Steroid Biochem Mol Biol; 2010 Feb; 118(4-5):311-5. PubMed ID: 19778609
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Proceedings of the VIII International Aromatase Conference, Baltimore, Maryland, USA, 18-20 September 2006.
    J Steroid Biochem Mol Biol; 2007; 106(1-5):1-186. PubMed ID: 18027398
    [No Abstract]   [Full Text] [Related]  

  • 5. Angela Hartley Brodie, 1934-2017: Assailant of Aromatase.
    Pederson T
    FASEB J; 2017 Oct; 31(10):4205-4206. PubMed ID: 28963317
    [No Abstract]   [Full Text] [Related]  

  • 6. Synthesis and aromatase inhibitory activity of some new 16E-arylidenosteroids.
    Bansal R; Thota S; Karkra N; Minu M; Zimmer C; Hartmann RW
    Bioorg Chem; 2012 Dec; 45():36-40. PubMed ID: 23064126
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Direct spectroscopic evidence for binding of anastrozole to the iron heme of human aromatase. Peering into the mechanism of aromatase inhibition.
    Maurelli S; Chiesa M; Giamello E; Di Nardo G; Ferrero VE; Gilardi G; Van Doorslaer S
    Chem Commun (Camb); 2011 Oct; 47(38):10737-9. PubMed ID: 21858332
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Optimization of the aromatase inhibitory activities of pyridylthiazole analogues of resveratrol.
    Mayhoub AS; Marler L; Kondratyuk TP; Park EJ; Pezzuto JM; Cushman M
    Bioorg Med Chem; 2012 Apr; 20(7):2427-34. PubMed ID: 22386564
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Design, synthesis and aromatase inhibitory activities of novel indole-imidazole derivatives.
    Wang R; Shi HF; Zhao JF; He YP; Zhang HB; Liu JP
    Bioorg Med Chem Lett; 2013 Mar; 23(6):1760-2. PubMed ID: 23403081
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Basic and Clinical Aspects of Aromatase. Proceedings of the 3rd International Aromatase Conference. Bologna, Italy, 14-17 June 1992.
    J Steroid Biochem Mol Biol; 1993 Mar; 44(4-6):321-696. PubMed ID: 8097403
    [No Abstract]   [Full Text] [Related]  

  • 11. Human aromatase: perspectives in biochemistry and biotechnology.
    Di Nardo G; Gilardi G
    Biotechnol Appl Biochem; 2013; 60(1):92-101. PubMed ID: 23586996
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Probing the binding pocket of the active site of aromatase with 2-phenylaliphatic androsta-1,4-diene-3,17-dione steroids.
    Takahashi M; Yamashita K; Numazawa M
    Steroids; 2010 Apr; 75(4-5):330-7. PubMed ID: 20096721
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A three-dimensional model of CYP19 aromatase for structure-based drug design.
    Karkola S; Höltje HD; Wähälä K
    J Steroid Biochem Mol Biol; 2007; 105(1-5):63-70. PubMed ID: 17583493
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis and biochemical studies of 17-substituted androst-3-enes and 3,4-epoxyandrostanes as aromatase inhibitors.
    Cepa MM; Tavares da Silva EJ; Correia-da-Silva G; Roleira FM; Teixeira NA
    Steroids; 2008 Dec; 73(14):1409-15. PubMed ID: 18691607
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular docking and QSAR study on steroidal compounds as aromatase inhibitors.
    Dai Y; Wang Q; Zhang X; Jia S; Zheng H; Feng D; Yu P
    Eur J Med Chem; 2010 Dec; 45(12):5612-20. PubMed ID: 20926163
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Discovery of a novel class of aldol-derived 1,2,3-triazoles: potent and selective inhibitors of human cytochrome P450 19A1 (aromatase).
    McNulty J; Nair JJ; Vurgun N; Difrancesco BR; Brown CE; Tsoi B; Crankshaw DJ; Holloway AC
    Bioorg Med Chem Lett; 2012 Jan; 22(1):718-22. PubMed ID: 22079757
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Proceedings of the VII International Aromatase Conference, Edinburgh, Scotland, United Kingdom, 6-8 September 2004.
    J Steroid Biochem Mol Biol; 2005 May; 95(1-5):1-187. PubMed ID: 15916894
    [No Abstract]   [Full Text] [Related]  

  • 18. Pharmacophore modeling strategies for the development of novel nonsteroidal inhibitors of human aromatase (CYP19).
    Muftuoglu Y; Mustata G
    Bioorg Med Chem Lett; 2010 May; 20(10):3050-64. PubMed ID: 20413308
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis of 6- or 4-functionalized indoles via a reductive cyclization approach and evaluation as aromatase inhibitors.
    Lézé MP; Palusczak A; Hartmann RW; Le Borgne M
    Bioorg Med Chem Lett; 2008 Aug; 18(16):4713-5. PubMed ID: 18640836
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Aromatase expression in health and disease.
    Simpson ER; Zhao Y; Agarwal VR; Michael MD; Bulun SE; Hinshelwood MM; Graham-Lorence S; Sun T; Fisher CR; Qin K; Mendelson CR
    Recent Prog Horm Res; 1997; 52():185-213; discussion 213-4. PubMed ID: 9238853
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.